Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Arthritis Rheumatol. 2015 Jan;67(1):128–139. doi: 10.1002/art.38892

Figure 3. Gut lumen and serum sIgA, RANKL, OPG and S100 levels.

Figure 3

(A) Levels of gut lumen sIgA are higher in PsA patients compared to controls, while measurements in serum revealed no differences among groups. (B) Fecal RANKL were not measurable in most PsA patients, while serum levels were similar among groups. (C) Levels of OPG in fecal samples were higher in Ps vs controls, but similar to those in PsA. (D) Serum S100 levels were significantly higher in Ps compared to PsA and controls. Note: Fecal samples were not available for fecal measurements for two healthy subjects. Fecal RANKL, OPG and S100 were not available in one PsA patient.